Aprilbio Co., Ltd. · KRX:397030

Aprilbio Co., Ltd. financial statements

Aprilbio Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue2.17B27.5B0200.0M23.4B150.0M
Gross profit2.17B27.5B200.0M23.4B150.0M
Research and development4.02B3.20B8.04B6.92B13.9B6.78B
Selling, general and administrative754.7M6.73B4.68B4.16B1.39B378.0M
Operating income-7.26B16.7B-13.4B-11.5B4.45B-9.19B
Depreciation and amortization689.6M705.6M674.4M593.4M487.3M361.4M
EBITDA-6.57B17.5B-12.7B-10.9B4.93B-8.83B
Interest expense618.9M1.42B930.5M29.8M2.11B1.28B
Income before tax-9.73B20.0B-14.1B-8.96B-52.7B-10.3B
Net income-9.73B20.0B-14.1B-8.96B-52.7B-10.2B
Earnings per share, basic-419.16891.67-654.93-424.17-2,506.63-487.79

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents7.07B3.35B6.59B7.28B24.4B10.1B
Short-term investments85.7B91.1B57.0B61.5B30.0B7.00B
Receivables1.47B480.0M255.8M4.29B51.4M
Current assets94.7B96.6B66.7B69.4B59.4B18.0B
Property, plant and equipment1.20B1.34B1.34B
Total assets97.1B99.6B79.7B71.1B61.4B19.4B
Current liabilities541.5M8.48B21.7B1.79B4.05B33.1B
Total liabilities803.8M8.61B22.0B1.90B4.21B33.2B
Shareholders' equity96.3B91.0B57.7B69.2B57.2B-13.8B
Shares outstanding23.2M22.4M21.6M21.1M21.0M21.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-3.34B22.0B-10.1B-6.70B3.25B-7.33B
Capital spending-287.8M-445.3M-512.0M-89.6M-705.8M-479.8M
Free cash flow-3.63B21.5B-10.6B-6.79B2.55B-7.81B
Cash from investing-22.8B-7.05B-31.6B
Cash from financing-2.51B16.3B20.3B
Share buybacks1.10B1.76B20.6B
Change in cash3.73B-3.24B-697.3M-17.1B14.2B3.51B